Table 2.
Parameters for high- and low-risk individuals for each intervention plan studied. Parameter ranges are provided whenever applicable. Upper-bound (ub) and low-bound (lb) parameters correspond to the high and low values provided in each range.
parameter | no interventions (high-risk: low-risk) | control measures (high-risk: low-risk) | antiviral intervention (high-risk: low-risk) | vaccine intervention (high-risk: low-risk) |
---|---|---|---|---|
(1.6–2.4 : 1.2–2) | (1.9 : 1.5) | (1.9 : 1.5) | (1.9 : 1.5) | |
ηi | (0.5 : 0.5) | (0.5 : 0.5) | (0.5 : 0.5) | (0.5 : 0.5) |
p | (0.5 : 0.5) | (0.5 : 0.5) | (0.5 : 0.5) | (0.5 : 0.5) |
ϕi | (1/1.9 : 1/1.9) | (1/1.9 : 1/1.9) | (1/1.9 : 1/1.9) | (1/1.9 : 1/1.9) |
ψi | (1/2 : 1/2) | (1/2 : 1/2) | (1/2 : 1/2) | (1/2 : 1/2) |
αi | (1/4 : 1/5) | (1/4 : 1/5) | (1/4 : 1/5) | (1/4 : 1/5) |
γIi | (1/5 : 1/4) | (1/5 : 1/4) | (1/5 : 1/4) | (1/5 : 1/4) |
γAi | (1/5 : 1/4) | (1/5 : 1/4) | (1/5 : 1/4) | (1/5 : 1/4) |
γHi | (1/7 : 1/5) | (1/7 : 1/5) | (1/7 : 1/5) | (1/7 : 1/5) |
CFPi | (0.15 : 0.03) | (0.15 : 0.03) | (0.15 : 0.03) | (0.15 : 0.03) |
δi | (1/33 : 1/100) | (1/33 : 1/100) | (1/33 : 1/100) | (1/33 : 1/100) |
πi | (1 : 1) | (0–1 : 0–1) | (1 : 1) | (1 : 1) |
ζi | (1 : 1) | (0–1 : 0–1) | (1 : 1) | (1 : 1) |
qi | (0 : 0) | (0 : 0) | (0.3–0.7 : 0.1–0.5) | (0 : 0) |
ai | (0 : 0) | (0 : 0) | (0.15–0.35 : 0.05–0.25) | (0 : 0) |
(0 : 0) | (0 : 0) | (0.3–0.5 : 0.5–0.7) | (0 : 0) | |
σi | (0 : 0) | (0 : 0) | (1/14 : 1/7) | (0 : 0) |
ρi | (0 : 0) | (0 : 0) | (1/3 : 1/5) | (0 : 0) |
θi | (0 : 0) | (0 : 0) | (1/3 : 1/5) | (0 : 0) |
ξi | (0 : 0) | (0 : 0) | (1 : 0.67) | (0 : 0) |
γT | (0 : 0) | (0 : 0) | (1/3)a | (0 : 0) |
(0 : 0) | (0 : 0) | (0 : 0) | (0.3–0.5 : 0.7–0.9) | |
νi | (0 : 0) | (0 : 0) | (0 : 0) | (1/2.7–1/1.5 : 1/2.7–1/1.5) |
κi | (0 : 0) | (0 : 0) | (0 : 0) | (1/7 : 1/7) |
This is not a risk-specific parameter.